Original from: labpulse.com
Abbott¡¯s new laboratory automation system has received U.S. Food and Drug Administration (FDA) approval, the company announced in a statement.
The Abbott GLP Systems Track has a self-propelled single-sample carrier called CAR, which allows samples to move independently in self-propelled cars throughout the track without a belt, a feature the firm says reduces mechanical failures and allows for full customization.
The system was designed to meet high-volume needs; it can manage up to 25,000 test tubes per day, reducing turnaround time for test results, the company said.
¡°We know that our customers are seeking flexibility and scalability in their laboratory operations so they can meet ever-growing demand,¡± said Louis Morrone, executive vice president for Abbott¡¯s core diagnostics business. ¡°GLP Systems Track addresses those needs, enabling labs to increase performance and improve the overall quality of their operations.¡±
Abbott noted that GLP Systems Track is not approved by the FDA for use in U.S. blood donor and plasma testing laboratories.
